The worldwide increase in diabetes is focusing more attention on all aspects of treatment, including associated hypertension. Untreated hypertension in people with diabetes is linked to high rates of cardiovascular and microvascular disease. Our update examines new evidence questioning the effectiveness of angiotensin II receptor antagonists for this co-morbidity. In addition, while the evidence supports the idea of aggressive blood pressure targets, we highlight the uncertainty surrounding the exact level of those targets.
Visit the Clinical Evidence website to see the full review.
Other useful links: